Product Program year 2021 Source: CMS Open Payments

MANTA Vascular Closure Device

Device Interventional Access

PDI 00856279007062

Open in the dashboard

General payments

$19,485

348 payments

Research payments

$8,905

8 payments

Through program year 2021, $19,485 in general payments and $8,905 in research payments were reported against MANTA Vascular Closure Device (Interventional Access).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $19,485 348
2021 Research $8,905 8

Breakdown

Who paid General payments · program year 2021
  1. Teleflex LLC $18,135 347 payments
  2. Arrow Interventional, Inc. $1,350 1 payment
Top recipients General payments · program year 2021
  1. Pedro Villablanca Spinetto Cardiovascular Disease · Detroit, MI $3,653 19% · 8 payments
  2. Paul Mahoney Interventional Cardiology · Greenville, NC $2,400 12% · 1 payment
  3. Robert Dewitt Thoracic Surgery (Cardiothoracic Vascular Surgery) · Alexandria, LA $1,350 7% · 1 payment
  4. James McCabe Interventional Cardiology · Seattle, WA $300 2% · 1 payment
  5. Naresh Solankhi Interventional Cardiology · Louisville, KY $241 1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Cardiology Internal Medicine $5,987 31% · 69 practitioners
  2. Cardiovascular Disease Internal Medicine $5,741 30% · 45 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,706 14% · 24 practitioners
  4. Vascular Surgery Surgery $1,753 9% · 55 practitioners
  5. Physician Assistant $716 4% · 16 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Michigan $5,194 27% · 33 recipients
  2. Virginia $2,425 12% · 3 recipients
  3. Texas $1,801 9% · 57 recipients
  4. Louisiana $1,440 7% · 4 recipients
  5. Florida $1,299 7% · 34 recipients

The top 5 of 38 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

348 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record